MedTrace Logo

Stepwise Screening for Silent Atrial Fibrillation After Stroke

NCT03570060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 264

Last updated 2024-06-25

No results posted yet for this study

Summary

The main hypothesis of this work is that an approach combining clinical parameters and biomarker assays could improve the understanding and prediction of the occurrence of silent atrial fibrillation (AF) in the acute phase after stroke. In this prospective work, the investigators will rely on the Dijon Stroke Registry, which collects extensive clinical data for each patient hospitalized for a stroke. As part of this registry, patients are seen 6 months after stroke to assess their clinical status. This clinical follow-up will allow us to judge the evolution of the AF diagnosed during the acute episode at a distance.

Conditions

  • Ischemic Cerebrovascular Accident

Interventions

BIOLOGICAL

Blood sample

2 ml of blood for testing for serum biomarkers (IL-6, GDF-15, soluble ST-2 soluble, osteoprotegerin, galectin 3)

PROCEDURE

Long term ECG monitor

Fitting and removal of a long term ECG monitor (SpiderFlash, LivaNova)

PROCEDURE

Monitoring ECG

Recording of automatic ECG monitor results (CSM Philips IntelliVue MP50 system)

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2023-03-23
Completion
2023-03-23

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03570060 on ClinicalTrials.gov